Pediatric End-stage Liver Disease Scores as a Method of Assessing Mortality Risk or Prioritization to Transplantability: Let Us Save the Children

Affiliations

¹ Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, University of Washington School of Medicine, Seattle.
² Division of Transplant Surgery, Department of Surgery, University of Washington School of Medicine, Seattle.

Editorial

Evelyn K Hsu et al. JAMA Pediatr. 2018.

. 2018 Nov 1;172(11):1015-1017.

doi: 10.1001/jamapediatrics.2018.2889.

¹ Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, University of Washington School of Medicine, Seattle.
² Division of Transplant Surgery, Department of Surgery, University of Washington School of Medicine, Seattle.

No abstract available

Comment on

Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.
Chang CH, Bryce CL, Shneider BL, Yabes JG, Ren Y, Zenarosa GL, Tomko H, Donnell DM, Squires RH, Roberts MS. Chang CH, et al. JAMA Pediatr. 2018 Nov 1;172(11):1070-1077. doi: 10.1001/jamapediatrics.2018.2541. JAMA Pediatr. 2018. PMID: 30242345 Free PMC article.
Is the Pediatric End-stage Liver Disease Score Truly a Detriment to Pediatric Liver Allocation?
Mahmud N, Gadsden MM, Goldberg DS. Mahmud N, et al. JAMA Pediatr. 2018 Nov 1;172(11):1013-1015. doi: 10.1001/jamapediatrics.2018.2886. JAMA Pediatr. 2018. PMID: 30242354 Free PMC article. No abstract available.